Zimmer Biomet COO Ivan Tornos appointed CEO

Zimmer Biomet appointed Ivan Tornos as President and CEO and elected him to the Board of Directors, effective immediately. Tornos most recently served as COO of Zimmer Biomet, a role he has held since early 2021. He takes over as President and CEO from Bryan Hanson, who has served as President and CEO since late 2017 and Chairman since 2021, and is departing to take on another CEO role. Suketu Upadhyay, who joined Zimmer Biomet in 2019 as EVP and CFO, is expanding his role to also include full responsibility for overseeing the company’s global Operations and Supply Chain functions. Additionally, current Lead Independent Director Christopher Begley takes on the role of Chairman of the Board. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. He was appointed COO in March 2021. Prior to joining Zimmer Biomet, Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Earlier, he was with C.R. Bard in positions of increasing responsibility, most recently serving as President, EMEA. Tornos currently serves as an independent member of the Board of Directors of global healthcare company PHC Holdings.